Skip to content
Open access

From staging to changing strategy: [18F]FDG PET/MRI's impact on treatment planning in early breast cancer.

Oct 2026 · European Journal of Cancer · Vol 249, pp. 117809 · 0 citations · 37 references
Medicine

TL;DR

MRI was highly informative for detecting multifocal disease, whereas the potential added value of [18F]FDG PET/MRI may primarily relate to integrated axillary and distant staging, however, its moderate diagnostic accuracy warrants caution to prevent overtreatment.

Abstract

INTRODUCTION Accurate staging at diagnosis is essential for optimizing treatment strategies and prognosis in early breast cancer (EBC). [18F]FDG positron emission tomography/magnetic resonance imaging (PET/MRI) is a hybrid imaging modality that enables simultaneous evaluation of locoregional disease and metastatic spread. This study assessed the impact of [18F]FDG PET/MRI on treatment planning in patients with EBC.

Methods

This unplanned sub-study derives from a prospective, interventional, single-arm clinical trial (SNB vs PET/MRI 2) conducted at San Raffaele University Hospital (Milan) between July 2020 and April 2024 (NCT04829643). Patients with EBC scheduled for primary surgery underwent additional preoperative [18F]FDG PET/MRI. The primary objective was the proportion of patients whose treatment strategy was modified following [18F]FDG PET/MRI findings and multidisciplinary discussion. The secondary objective was the performance of [18F]FDG PET/MRI in detecting multifocal breast cancer compared with standard imaging.

Results

A total of 264 patients were analyzed. [18F]FDG PET/MRI led to treatment plan modifications 30.7% (81/264, 95% CI: 25.4%-36.5%) of patients. Surgical approach was altered in 23.9% (63/264), while 4.9% (13/264) received primary systemic therapy and 1.9% (5/264) were referred for systemic therapy alone. [18F]FDG PET/MRI showed a sensitivity of 61.7%, specificity of 84.9%, positive predictive value (PPV) of 49.2%, and negative predictive value (NPV) of 90.4% for multifocal disease detection. When combined with standard imaging, PPV increased to 63.6%; sensitivity was 29.8%.

Conclusions

[18F]FDG PET/MRI substantially influences treatment decisions in EBC, modifying management in nearly one-third of patients. MRI was highly informative for detecting multifocal disease, whereas the potential added value of [18F]FDG PET/MRI may primarily relate to integrated axillary and distant staging. However, its moderate diagnostic accuracy warrants caution to prevent overtreatment.

Read PDF

Similar papers

Open access Oct 2026

Predictive value of preoperative [18F]FDG PET/CT imaging parameters for postoperative recurrence and metastasis in breast cancer patients

Purpose To assess the predictive value of preoperative 2-deoxy-2-[¹8F]fluoro-D-glucose positron emission tomography/computed tomography ([18F]FDG PET/CT) imaging parameters in forecasting the recurrence and metastasis following surgery among individuals diagnosed with early-stage breast cancer. Methods A retrospective...

N. Lin, Chao Ren, Zhe Wen · 0 citations
Oct 2026

Reconsidering the Value of Baseline PET/CT in Early-Stage Breast Cancer: Evidence for Selective Use from the MF21-02 Multicenter Study

Background: The role of ^18F-FDG PET/CT in the initial staging of early-stage breast cancer remains controversial, as current guidelines discourage its routine use due to the low prevalence of distant metastases. This study aimed to evaluate the diagnostic yield and clinical impact of baseline PET/CT in a large multice...

M. A. Nazlı, O. Toktaş, S. Özbaş et al. · 0 citations
Open access Oct 2026

Early Dynamic 18F-FDG PET/CT SUVmax and Its Association with Pathological Stage and Tumor Grade in Bladder Cancer: A Prospective Exploratory Study

Early dynamic 18F-FDG PET/CT imaging at 0–2 min showed the highest, although modest, diagnostic performance among the evaluated time points for predicting tumor grade and muscle invasion.

B. Saylam, Berfin Temelli, Ali Nebi̇oğlu et al. · 0 citations
Open access Oct 2026

[18F]fluorodeoxyglucose PET/CT refines staging and treatment selection in high-risk upper tract urothelial carcinoma.

OBJECTIVES To evaluate the incremental clinical value of [18F]fluorodeoxyglucose positron emission tomography/computed tomography ([18F]FDG-PET/CT) beyond contrast-enhanced computed tomography (CECT) for primary staging of suspected high-risk upper tract urothelial carcinoma (UTUC). PATIENTS AND METHODS We conducted...

R. A. G. Lijnen, J. Ringia, K. Hendricksen et al. · 0 citations
Open access Oct 2026

The Additional Role of the Quantitative Measurements of 18F-FDG PEM Compared to PET/CT in the Evaluation of Post Interventional Breast Neoplasm

PEM offers superior spatial resolution and provides complementary metabolic information to PET/CT, particularly in small or multifocal lesions, particularly in small or multifocal lesions.

N. Ali, Hashem Mohamed, A. Kandeel et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.